Your session is about to expire
← Back to Search
Home monitoring program patients for Congenital Heart Defects (Heart@Home Trial)
N/A
Recruiting
Led By Carolyn C Foster, MD, MS
Research Sponsored by Ann & Robert H Lurie Children's Hospital of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 14 days per patient of data collection
Awards & highlights
No Placebo-Only Group
Summary
The overall goal of this study is to understand the feasibility of using a wireless sensor device (instead of a wired device) to collect information used to monitor children with heart conditions at home.
Eligible Conditions
- Congenital Heart Defects
- Congenital Heart Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 14 days per patient of data collection
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 14 days per patient of data collection
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Physiologic measurements
Secondary study objectives
Systems Usability Score
Utilization
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Home monitoring program patientsExperimental Treatment1 Intervention
Patients enrolled in the study are those patients who are already enrolled in (or are being discharged with) home monitoring in an existing program
Find a Location
Who is running the clinical trial?
Sibel Health Inc.Industry Sponsor
4 Previous Clinical Trials
357 Total Patients Enrolled
Ann & Robert H Lurie Children's Hospital of ChicagoLead Sponsor
264 Previous Clinical Trials
5,182,654 Total Patients Enrolled
Carolyn C Foster, MD, MSPrincipal InvestigatorAnn and Robert H. Lurie Children's Hospital of Chicago
1 Previous Clinical Trials
50 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger